Suicidal Behavior and Severe Neuropsychiatric Disorders Following Glucocorticoid Therapy in Primary Care
The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: The incidence and the risk of suicidal behaviors and severe neuropsychiatric disorders in people treated with systemic glucocorticoids are poorly known. The authors assessed the incidence rates of depression, mania, delirium, panic disorder, and suicidal behaviors in patients treated with glucocorticoids in primary care settings and the risk factors for developing these outcomes. METHOD: Data were obtained for all adult patients registered between 1990 and 2008 at U.K. general practices contributing to The Health Improvement Network (THIN) primary care database. The incidence rates for the outcomes of interest were assessed in patients who received prescriptions for oral glucocorticoids and compared with those in patients who did not receive such prescriptions. The predictors of these outcomes in exposed patients were ascertained using Cox proportional hazards models. RESULTS: Overall, 786,868 courses of oral glucocorticoids were prescribed for 372,696 patients. The authors identified 109 incident cases of suicide or suicide attempt and 10,220 incident cases of severe neuropsychiatric disorders in these patients. The incidence of any of these outcomes was 22.2 per 100 person-years at risk for first-course treatments. Compared to people with the same underlying medical disease who were not treated with glucocorticoids, the hazard ratio for suicide or suicide attempt in exposed patients was 6.89 (95% CI=4.52–10.50); for depression, 1.83 (95% CI=1.72–1.94); for mania, 4.35 (95% CI=3.67–5.16); for delirium, confusion, or disorientation, 5.14 (95% CI=4.54–5.82); and for panic disorder, 1.45 (95% CI=1.15–1.85). Older men were at higher risk of delirium/confusion/disorientation and mania, while younger patients were at higher risk of suicide or suicide attempt. Patients with a previous history of neuropsychiatric disorders and those treated with higher dosages of glucocorticoids were at greater risk of neuropsychiatric outcomes. CONCLUSIONS: Glucocorticoids increase the risk of suicidal behavior and neuropsychiatric disorders. Educating patients and their families about these adverse events and increasing primary care physicians' awareness about their occurrence should facilitate early monitoring.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Two meta-analyses 64,65 concluded that cortisol levels in MDD were elevated, with a moderate effect size.”
From Major depressive disorder (2016) · cites this paper as [65]
Citations
Cites
Mechanisms involved in the side effects of glucocorticoids
SCHACKE, H. (2002) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(02)00297-8 · Cited by 1,847 · cited 1×
“Natural glucocorticoids such as cortisol affect behavior, mood, and other CNS-related processes (1).”
BackgroundDiagnosis and complications of Cushing’s syndrome: a consensus statement
Arnaldi, G., Angeli, A., Atkinson, A. B., Bertagna, X., Cavagnini, F., Chrousos, G. P., Fava, G. A., Findling, J. W., Gaillard, R. C., Grossman, A. B., et al. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030871 · Cited by 1,362
Validation and validity of diagnoses in the General Practice Research Database: a systematic review
Herrett, E., Thomas, S. L., Schoonen, W. M., Smeeth, L., & Hall, A. J. (2010) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2009.03537.x · Cited by 1,109
Psychiatric Adverse Effects of Corticosteroids
Warrington, T. P., & Bostwick, J. M. (2006) · Mayo Clinic Proceedings · doi:10.4065/81.10.1361 · Cited by 611
Lewis, J. D., Schinnar, R., Bilker, W. B., Wang, X., & Strom, B. L. (2007) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1335 · Cited by 602
Population‐based assessment of adverse events associated with long‐term glucocorticoid use
Curtis, J. R., Westfall, A. O., Allison, J., Bijlsma, J. W., Freeman, A., George, V., Kovac, S. H., Spettell, C. M., & Saag, K. G. (2006) · Arthritis Care & Research · doi:10.1002/art.21984 · Cited by 595
Use of oral corticosteroids in the United Kingdom
van Staa, T. P. (2000) · QJM · doi:10.1093/qjmed/93.2.105 · Cited by 529
Steroid-induced psychiatric syndromes
Lewis, D. A., & Smith, R. E. (1983) · Journal of Affective Disorders · doi:10.1016/0165-0327(83)90022-8 · Cited by 528
The Read clinical classification.
Chisholm, J. (1990) · BMJ · doi:10.1136/bmj.300.6732.1092 · Cited by 504
Walsh, L. J., Wong, C. A., Pringle, M., & Tattersfield, A. E. (1996) · BMJ · doi:10.1136/bmj.313.7053.344 · Cited by 383
Research works printed but not linked: 2
- CSD Medical Research/EPIC, 2007, THIN Data From EPIC: A Guide for Researchers
- Reckart MD, 1990, Int J Psychosom, 37, 57
Cited by
Items 201–300 of 315
Suicide risk in systemic lupus erythematosus: a narrative review
Barros, S. M., de Araújo, D. B., & de Carvalho, J. F. (2020) · Revista de Ciências Médicas e Biológicas · doi:10.9771/cmbio.v19i4.24308 · Cited by 1
Immunosuppressive agents and monitoring in long‐term survivors
Culos, K. A. A., & Gatwood, K. S. (2021) · Wiley eBooks · doi:10.1002/9781119612780.ch37 · Cited by 1
Shipley, S. R., Clark, M. S., & Norris, D. R. (2022) · Springer eBooks · doi:10.1007/978-3-030-54441-6_34 · Cited by 1
Hansen, N., Neyazi, A., Lüdecke, D., Hasan, A., Wiltfang, J., & Malchow, B. (2022) · Journal of Neural Transmission · doi:10.1007/s00702-022-02578-2 · Cited by 1
Nakamura, T., Kuraishi, Y., Ohya, D., Kimura, K., Sasayama, D., & Washizuka, S. (2024) · Neuropsychopharmacology Reports · doi:10.1002/npr2.12463 · Cited by 1
“Prednisolone is known to increase the incidence of depression 11 ; FIGURE 1 Motivation, appetite, and neuropsychotropic during psychiatric intervention.”
BackgroundЧорномидз, А. В., Чорномидз, І. Б., & Чорномидз, Ю. А. (2025) · Psychosomatic Medicine and General Practice · doi:10.26766/pmgp.v10i4.684 · Cited by 1
Use of Clinical Notes to Assess Neuropsychiatric Events After Montelukast Initiation
Jaffe, D. H., Berliner, E., Balkaran, B. L., Yue, A., Finlayson, K., Guijon, O. L., Chu, M. M., Ehwerhemuepha, L., Seluk, L., Wechsler, M. E., et al. (2026) · JAMA Network Open · doi:10.1001/jamanetworkopen.2025.58433 · Cited by 1
Developmental Mechanisms in Gene-by-Intervention (GxI) Effects in the Fast Track Trial
Dodge, K. A. (2017) · Springer eBooks · doi:10.1007/978-3-319-49227-8_12 · Cited by 1
Comorbidity in Graves' Orbitopathy
Žarković, M., & Knežević, M. (2017) · KARGER eBooks · doi:10.1159/000475969 · Cited by 1
Differential Diagnosis of Abnormal Symptoms and Signs
Ettinger, A. B., & Weisbrot, D. M. (2014) · Cambridge University Press eBooks · doi:10.1017/cbo9781139028899.003 · Cited by 1
A review of suicidality in nonpsychotropic medications
Koch, J. M., Ward, S. L., Martin, B., & Thomas, C. (2015) · Mental Health Clinician · doi:10.9740/mhc.2015.09.224 · Cited by 1
The Wrath of Steroids in Elderly Patients with Pulmonary Diseases
Beckert, A. K., & Duthie, E. H. (2016) · Current Geriatrics Reports · doi:10.1007/s13670-016-0171-z · Cited by 1
Glucocorticoid Regulation of Neurocognitive and Neuropsychiatric Function
Pereira, A. M., & Meijer, O. C. (2016) · Springer eBooks · doi:10.1007/978-3-319-45950-9_2 · Cited by 1
“The acute and long-term effects on both mood and cognition have been studied in prospective studies, and the severe neuropsychiatric effects in case studies and with the use of epidemiological databases [92].”
BackgroundHipomanía y corticoides en pacientes oncológicos. Reporte de un caso y revisión de la literatura
Paulina Troncoso, G., & Mosher, P. J. (2018) · Revista chilena de neuro-psiquiatría · doi:10.4067/s0717-92272018000300169 · Cited by 1
Epigenetics of major depressive disorder
Braun, P., & Potash, J. B. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-823577-5.00002-7 · Cited by 1
High on steroids: manische episode na gebruik van corticosteroïden
Queecker, K. D., & Vandenberghe, J. (2021) · Tijdschrift voor Geneeskunde · doi:10.47671/tvg.77.21.138 · Cited by 1
Exposure Therapy when Patients Present with Asthma
Kroll, J. L., & Meuret, A. E. (2022) · Springer eBooks · doi:10.1007/978-3-031-04927-9_10 · Cited by 1
Mood Disorders Associated with Glucocorticoid Therapy: Causes, Mechanisms, and Remediation
Deorah, N. (2022) · International journal of high school research · doi:10.36838/v4i5.4 · Cited by 1
Shermon, S., Maclean, J., Shim, R., & Kim, C. H. (2024) · Pain Physician · doi:10.36076/ppj.2024.7.149 · Cited by 1
Kondo, S., Kurihara, M., Higashihara, M., Hara, M., Nishina, Y., Iwakiri, R., Murayama, S., Saito, Y., & Iwata, A. (2024) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/ggi.14922 · Cited by 1
Increased Risk of Suicide Attempts Among Adolescents With Food Allergy in the United States
Kalra, S., Kleiman, E. M., Rizvi, S. L., Grafova, I. B., Duberstein, P. R., & Kalra, D. (2024) · JAACAP Open · doi:10.1016/j.jaacop.2024.11.005 · Cited by 1
“…age groups and datasets, while also considering the effects of other allergies, 18,32,33 medications used to manage FA (such as glucocorticoids, 34 antihistamines, 35 and montelukast sodium 36 ), experiences of family violence, and the presence of neurodevelopmental disorders, all of which are…”
Lacourt, T. E., Schubert, M. C., Siddiqui, B. A., Subudhi, S. K., & Chopra, D. A. (2025) · Supportive Care in Cancer · doi:10.1007/s00520-025-10083-x · Cited by 1
“Such effects range from mild to severe (including suicidal behavior), but quantifying this range has been difficult due to the focus on physical adverse effects and variability in study outcomes [5–8].”
Overlap and common correlates between depression and COPD: a narrative review
Iannuzzo, F., Nucera, F., Bruno, A., Anna, M. M. R., & Caramori, G. (2023) · Mediterranean Journal of Clinical Psychology · doi:10.13129/2282-1619/mjcp-3656 · Cited by 1
Sergeant, C. A. (2017) · SUNScholar (Stellenbosch University) · Cited by 1
Kirby, J. (2018) · uO Research (University of Ottawa) · doi:10.20381/ruor-21514 · Cited by 1
Crook, A. L. (2019) · ERA · Cited by 1
Hair cortisol as a biomarker for mood in bipolar disorder: a pilot studyPreprint
Maimon, L., Milo, T., Haran, D., Cohen, B., Danon, T., Bren, A., Mayo, A., Rappaport, G. C., & Alon, U. S. (2023) · Research Square · doi:10.21203/rs.3.rs-2484487/v1 · Cited by 1
Callejas, R. Á. (2020) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · Cited by 1
Arcego, D. M., Pokhvisneva, I., Buschdorf, J. P., O’Toole, N., Patel, S. H., de Lima, R. M. S., Elgbeili, G., Lee, P., Frosi, G., Fiori, L. M., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.01.14.699350 · Cited by 1
Glucocorticoid receptor activity in triple negative breast cancer
Noureddine, L. M. (2022) · theses.fr (ABES) · doi:10.70675/13ab50cfz7edbz4a44z918aza657b9614a4d · Cited by 1
Visual hallucinations: a review for ophthalmologists
Hashemi, N., Scranton, R. A., Hashemi, M., & Lee, A. G. (2012) · Expert Review of Ophthalmology · doi:10.1586/eop.12.53
Physical illness and psychiatric comorbidity
Williams, S., & Rajapakse, T. N. (2013) · Sri Lanka Journal of Psychiatry · doi:10.4038/sljpsyc.v4i1.5725
Meduri, G. U., & Shih, M. (2012) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2012.12040498
Shipley, S. R., Clark, M. S., & Norris, D. R. (2015) · Springer eBooks · doi:10.1007/978-1-4939-0779-3_34-1
Central nervous system lupus – three different manifestations of the disease
Koszarny, A., Parada-Turska, J., & Majdan, M. (2013) · Reumatologia/Rheumatology · doi:10.5114/reum.2013.33401
“Wykazano, że w populacji osób stosujących przewlekle GKS zachowania samobójcze są częstsze, niezależnie od choroby psychicznej, zwiększone jest także ryzyko pojawienia się zaburzeń neuropsychiatrycznych, szczególnie u osób starszych [9].”
Self-Decapitation Attempt Attributed to Tinnitus and Oral
Meyer, A., & Miller, S. M. (2015)
Exogenous corticosteroids and dog behaviour
Notari, L. (2016) · Lincoln Repository (University of Lincoln) · doi:10.24385/lincoln.24325582
Corticotrophins, corticosteroids, and prostaglandins
Costa, J., & Farré, M. (2011) · Side effects of drugs annual · doi:10.1016/b978-0-444-53741-6.00039-8
Does Having Exophthalmic Graves’ Disease Increase a Patient's Risk of Suicide?
Spaulding, S. W. (2017) · Clinical Thyroidology · doi:10.1089/ct.2017;29.450-453
Neuropsychiatric Complications of Steroids
Corbett, B. M., & Wilson, M. P. (2017) · Springer eBooks · doi:10.1007/978-3-319-58260-3_52
Effects of Glucocorticoids on the Brain
Pereira, A. M., Webb, S. M., & Meijer, O. C. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.64329-5
Braun, P., Bassuk, A. G., Weiner, J. A., Potash, J. B., Michaelson, J. J., & Stevens, H. E. (2018) · doi:10.17077/etd.mthqnslt
CORTICOSTEROIDS - (UN)PREDICTABLE INDUCERS OF PSYCHIATRIC DISORDERS
Telbizova, T., & Arnaoudova, M. (2019) · Journal of IMAB - Annual Proceeding (Scientific Papers) · doi:10.5272/jimab.2019254.2775
Clarke, M. (2019) · Carleton University's Institutional Repository (MacOdrum Library, Carleton University) · doi:10.22215/etd/2019-13740
“Additional evidence of a causative relationship is provided by studies showing that treatment with synthetic glucocorticoids is associated with increased risk of both suicide and depression (Fardet et al., 2012).”
BackgroundWhat Is Suicidal Behavior, and Can It Be Prevented?
van Heeringen, K. (2018) · Cambridge University Press eBooks · doi:10.1017/9781316563205.002
“In my end is my beginning”: A Neurodevelopmental Perspective on Suicidal Behavior*
van Heeringen, K. (2018) · Cambridge University Press eBooks · doi:10.1017/9781316563205.008
I Predict, Therefore I Cannot Be: A Predictive Coding Account of Suicidal Behavior
van Heeringen, K. (2018) · Cambridge University Press eBooks · doi:10.1017/9781316563205.009
Predicting the Unpredictable: Neuroscience Contributions to Suicide Prediction
van Heeringen, K. (2018) · Cambridge University Press eBooks · doi:10.1017/9781316563205.010
The Dark Side of the Brain: Neuroscience Approaches to Suicidal Behavior
van Heeringen, K. (2018) · Cambridge University Press eBooks · doi:10.1017/9781316563205.004
Kaufman, D. M., Geyer, H. L., & Milstein, M. J. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-41559-0.00015-0
Neuropsychiatric Complications
Moreno, E. A., & Strouse, T. B. (2015) · Elsevier eBooks · doi:10.1016/b978-1-4557-0268-8.00081-6
Pharmacokinetics of Anti-Rheumatic Drugs in a Geriatric Patient
Goldstein, L. H. (2020) · Springer eBooks · doi:10.1007/978-3-030-44234-7_5
Adverse events in clinical studies in rheumatoid arthritis
Yates, M., & Galloway, J. B. (2020) · Oxford University Press eBooks · doi:10.1093/med/9780198831433.003.0039
Glukokortikoid Kullanan Hastanın Yönetimi
Akdeniz, Y. Ş., Pişkinpaşa, H., Esen, A. D., Karakaya, P., Doğanşen, S. Ç., Okuturlar, Y., & Mert, M. (2018) · Klinik Tıp Aile Hekimliği
The Treatment of Suicide Risk: Neuroscience Aspects
van Heeringen, K. (2018) · Cambridge University Press eBooks · doi:10.1017/9781316563205.011
Effects of Dexamethasone and Brain-Derived Neurotropic Factor in NT2 Cells
Alharthi, S., Tchao, R., & Tejani‐Butt, S. M. (2020) · International Journal of Sciences: Basic and Applied Research
Enabling personalized medicine through pharmacokinetic modeling
Scherholz, M. L. (2019) · doi:10.7282/t3-2ry2-4f60
Zhang, B., Yang, M., Yan, Q., Xu, X., Niu, F., Dong, J., Zhuang, Y., Lu, S.-H., Ge, Q., & Liu, B. (2021) · Research Square · doi:10.21203/rs.3.rs-520614/v1
Images of the Suicidal Brain: Systems Neuroscience and Suicide
van Heeringen, K. (2018) · Cambridge University Press eBooks · doi:10.1017/9781316563205.007
Methylomic and transcriptomic predictors of one-month exposure to cortisol in healthy individuals
Lee, R. S., Zandi, P. P., Lin, Y., Seifuddin, F., Benke, K. S., McCaul, M. E., Reitz, K., & Wand, G. S. (2021) · Stress · doi:10.1080/10253890.2021.1946509
“It is a catalyst for initiation of cardiovascular, metabolic, and CNS disorders as well as an accelerant of aging (Arnsten, 2015; Bose et al., 2009; Brydon et al., 2006; Fardet et al., 2012; Hackett & Steptoe, 2016; Kelly & Ismail, 2015; McKlveen et al., 2016; Rahman et al., 2016).”
BackgroundI Think, Therefore I Do Not Want to Be: The Cognitive Neuroscience of Suicidal Behavior
van Heeringen, K. (2018) · Cambridge University Press eBooks · doi:10.1017/9781316563205.006
Suicide risk in systemic lupus erythematosus: A narrative review
Barros, S. M., & de Carvalho, J. F. (2021) · Discussion of Clinical Cases · doi:10.5430/dcc.v8n3p9
(2018) · Cambridge University Press eBooks · doi:10.1017/9781316563205.013
van Heeringen, K. (2018) · Cambridge University Press eBooks · doi:10.1017/9781316563205.015
van Heeringen, K. (2018) · Cambridge University Press eBooks · doi:10.1017/9781316563205.001
Lethal Signals: The Molecular Neuroscience of Suicidal Behavior
van Heeringen, K. (2018) · Cambridge University Press eBooks · doi:10.1017/9781316563205.005
van Heeringen, K. (2018) · Cambridge University Press eBooks · doi:10.1017/9781316563205.012
Behavioral medical epigenetics
Cox, O., & Lee, R. S. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-823928-5.00017-7
Jacobs, J. W. G., van der Goes, M. C., Bijlsma, J. W. J., & da Silva, J. A. P. (2020) · Oxford University Press eBooks · doi:10.1093/med/9780198831433.003.0029
Shipley, S. R., Clark, M. S., & Norris, D. R. (2020) · Springer eBooks · doi:10.1007/978-1-4939-0779-3_34-2
Corticotrophins, Corticosteroids and Prostaglandins
Costa, J., & Farré, M. (2014) · Side effects of drugs annual · doi:10.1016/b978-0-444-63407-8.00039-3
Shipley, S. R., Clark, M. S., & Norris, D. R. (2016) · Springer eBooks · doi:10.1007/978-3-319-04414-9_34
Ritz, T., Kroll, J. L., Kulikova, A., Werchan, C. A., & Brown, E. (2018) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615371990.jl18
van Heeringen, K. (2018) · Cambridge University Press eBooks · doi:10.1017/9781316563205.014
Nakhla, E., & Gelot, S. R. (2014) · Springer eBooks · doi:10.1007/978-1-4614-9194-1_558
Kaufman, D. M., Geyer, H. L., Milstein, M. J., & Rosengard, J. L. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-79680-4.00015-2
Manic Episode in an Acute Disseminated Encephalomyelitis
Gourani, A., Akebour, K., Berghalout, M., Adali, I., & Manoudi, F. (2022) · Scholars Journal of Medical Case Reports · doi:10.36347/sjmcr.2022.v10i07.037
Wark, G., Samocha‐Bonet, D., Ghaly, S., & Danta, M. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-821848-8.00104-9
A Practice Pilot Survey on the Current Use of Corticosteroid Therapy in Brain Tumor Patients
Panda, P. K., Gupta, T., & Jalali, R. (2022) · Neurology India · doi:10.4103/0028-3886.359216
Silva, M., & Carrasco, V. (2022) · Psychiatry Research Case Reports · doi:10.1016/j.psycr.2022.100086
Psychiatric Impact of Glucocorticoids in Organ Transplantation
Rosen, J. H. (2022) · Springer eBooks · doi:10.1007/978-3-031-15052-4_34
Deakandi, W. Y., Ni’mah, N. L., Rusdiana, A., Nuzula, T. M., & Mutaqin, F. (2023) · International Journal Of Scientific Advances · doi:10.51542/ijscia.v4i1.20
(2023) · Aerospace Medicine and Human Performance · doi:10.3357/amhp.6226.2023
Gopaul, D., & Justiz-Vaillant, A. A. (2023) · Preprints.org · doi:10.20944/preprints202309.2018.v1
How Are Adjuvant Medications Such as Corticosteroids and NSAIDs Used for Pain Management?
Chilsen, A., Morphew, J., & Kamal, A. H. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-84702-5.00007-5
Steroid-induced Psychosis in a Patient without a Previous Psychiatric History
Avila, C., Horowitz, R., & Arreaza, H. (2023) · Journal of the National Hispanic Medical Association · doi:10.59867/nhma0203
Morfín, J. A., & Nizamic, T. J. (2023) · Springer eBooks · doi:10.1007/978-3-030-01782-8_56-1
Kapfhammer, H. (2023) · Springer eBooks · doi:10.1007/978-3-662-68309-5_7
Gillespie, C. F., & Nemeroff, C. B. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-19176-3.00046-7
Chapter 14. Dermatology: Psychiatric Considerations in the Medical Setting
Taylor, K. A., Gordon-Elliott, J. S., & Muskin, P. R. (2020) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615378869.lg14
Sleep in pediatric oncology: measuring, identifying and intervening
Peersmann, S. H. M. (2024) · doi:10.5463/thesis.886
Sleep, depression, anxiety and quality of life in patients with systemic lupus erythematosus
Franco, L. W., Bauer, I. S., dos Santos, T. A. F. G., Nisihara, R., & Skare, T. L. (2025) · The Egyptian Rheumatologist · doi:10.1016/j.ejr.2025.04.001
Manimozhi, T., Karthik, P., Raja, M. C., & Mirajkar, A. (2025) · International Journal of Science and Research (IJSR) · doi:10.21275/mr25424120251
Insulin/IGF-1 signaling modulation in prefrontal cortex is linked to antisuicidal effects in MDDPreprint
Artomov, M., Pinakhina, D. V., Kasyanov, E. D., Larin, A. K., Veselovsky, V. A., Rakitko, A., Незнанов, Н. Г., Rukavishnikov, G. V., Kibitov, A. O., & Mazo, G. (2025) · Research Square · doi:10.21203/rs.3.rs-5806920/v1
Single Health System RCT Addressing Corticosteroid Injection Use in Treating Adults with ARTIs
Dvorin, E. L., Gastañaduy, M., Scott, M., Santaolaya, C., & Zia, A. (2025) · Journal of General Internal Medicine · doi:10.1007/s11606-025-09922-8
Salehzadeh Moghadami, M. (2024) · cIRcle (University of British Columbia) · doi:10.14288/1.0445135
Glucocorticoid Therapy and Suicidal Behavior – a case report
Silva, S., & Madeira, N. (2015) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Metadata
- Authors
- Fardet, L., Petersen, I., & Nazareth, I.
- Affiliations
- The Royal Free Hospital (GB)
- Venue
- American Journal of Psychiatry
- Published
- 2012-05
- Volume
- 169
- Issue
- 5
- Pages
- 491-497
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- OpenAlex
- W1972710070
- Semantic Scholar
- 685aae4b79751dcc2039c2233ce3afa9e737b047
- Cited by
- 287
- References
- 35
- Citations by year
- 2026: 12 · 2025: 14 · 2024: 18 · 2023: 20 · 2022: 20 · 2021: 30 · 2020: 25 · 2019: 9 · 2018: 40 · 2017: 18 · 2016: 23 · 2015: 15 · 2014: 21 · 2013: 13 · 2012: 7
- FWCI
- 20.28
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- American Journal of Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Topics
- Social Sciences › Psychology › Clinical Psychology › Suicide and Self-Harm Studies
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pharmacovigilance and Adverse Drug Reactions
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- glucocorticoids, suicidal behavior, suicide attempts, neuropsychiatric disorders, depression, mania, delirium, panic disorder, adverse drug reactions, primary care, incidence, risk factors, glucocorticoid dose, older men, young men, patient education, adverse event monitoring, primary care prescribing, pharmacovigilance, antipsychotic prescribing
- MeSH terms
- Mental Disorders, Bipolar Disorder, Confusion, Delirium, Depression, Female, Glucocorticoids, United Kingdom, Humans, Male, Middle Aged, Primary Health Care, Risk Factors, Suicide, Suicide, Attempted, Proportional Hazards Models, Panic Disorder
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.